Arkolith/Insider Trading/CYT/Form 4

Gaiero David G

Chief Financial OfficerCyteir Therapeutics, Inc. (CYT) · full profile →Form 4 · filed Mar 5, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
3 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 4, 2024Option exercise(M)2K$1.69$4K102K
Feb 29, 2024Option exercise(M)3K$1.68$5K95K
Feb 29, 2024Option exercise(M)5K$1.69$8K100K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 4, 2024Option exercise(M)2K—$083K
Feb 29, 2024Option exercise(M)3K—$016K
Feb 29, 2024Option exercise(M)5K—$085K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-24-004439) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML